Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial

Nutrition

Volumn 57, Issue , 2019, Pages 154-161

  Rezaei, Shahla ^a   Akhlaghi, Masoumeh ^b   Sasani, Mohammad Reza ^c   Barati Boldaji, Reza ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body composition; Body fat percentage; Fatty liver grade; Non alcoholic fatty liver disease; Olive oil

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OLIVE OIL; SUNFLOWER OIL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FAT FREE MASS; FAT MASS; FEMALE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN RESISTANCE; LIVER WEIGHT; LOW CALORIE DIET; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; BLOOD; BLOOD PRESSURE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; COMPLICATION; DRUG EFFECT; ENZYMOLOGY; FAT INTAKE; LIVER; METABOLISM; MIDDLE AGED; OBESITY; OLIVE TREE; PATHOLOGY; PHARMACOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD PRESSURE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; DIET, REDUCING; DIETARY FATS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OLEA; OLIVE OIL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 85052307629     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2018.02.021     Document Type: Article

References (40)

1. Hassan, K., Bhalla, V., El Regal, M.E., A-Kader HH. Nonalcoholic fatty liver disease: comprehensive review of a growing epidemic. World J Gastroenterol 20 (2014), 12082–12101.
2. Bellentani, S., The epidemiology of non-alcoholic fatty liver disease. Liver Int 37 (2017), 81–84.
3. Grander, C., Grabherr, F., Moschen, A.R., Tilg, H., Non-alcoholic fatty liver disease: cause or effect of metabolic syndrome. Visc Med 32 (2016), 329–334.
4. Rinella, M.E., Nonalcoholic fatty liver disease: a systematic review. JAMA 313 (2015), 2263–2273.
5. Hernandez-Rodas, M.C., Valenzuela, R., Videla, L.A., Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease. Int J Mol Sci 16 (2015), 25168–25198.
6. Koppe, S.W., Obesity and the liver: nonalcoholic fatty liver disease. Transl Res 164 (2014), 312–322.
7. Dinu, M., Pagliai, G., Casini, A., Sofi, F., Mediterranean diet and multiple health outcomes: An umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr 72 (2018), 30–43.
8. Pérez-Martínez, P., García-Ríos, A., Delgado-Lista, J., Pérez-Jiménez, F., López-Miranda, J., Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr Pharm Des 17 (2011), 769–777.
9. Buckland, G., Gonzalez, C.A., The role of olive oil in disease prevention: a focus on the recent epidemiological evidence from cohort studies and dietary intervention trials. Br J Nutr 113 (2015), S94–101.
10. Nigam, P., Bhatt, S., Misra, A., Chadha, D.S., Vaidya, M., Dasgupta, J., et al. Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male Asian Indians with nonalcoholic fatty liver disease. Diabetes Technol Ther 16 (2014), 255–261.
11. Scorletti, E., Byrne, C.D., Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu Rev Nutr 33 (2013), 231–248.
12. Jentzsch, A.M., Bachmann, H., Fürst, P., Biesalski, H.K., Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20 (1996), 251–256.
13. Kurtze, N., Rangul, V., Hustvedt, B.E., Reliability and validity of the international physical activity questionnaire in the Nord-Trøndelag health study (HUNT) population of men. BMC Med Res Methodol, 8, 2008, 63.
14. Guarrasi, V., Mangione, M.R., Sanfratello, V., Martorana, V., Bulone, D., Quantification of underivatized fatty acids from vegetable oils by HPLC with UV detection. J Chromatogr Sci 48 (2010), 663–668.
15. Akhlaghi, M., Non-alcoholic fatty liver disease: Beneficial effects of flavonoids. Phytother Res 30 (2016), 1559–1571.
16. Bozzetto, L., Costabile, G., Luongo, D., Naviglio, D., Cicala, V., Piantadosi, C., et al. Reduction in liver fat by dietary MUFA in type 2 diabetes is helped by enhanced hepatic fat oxidation. Diabetologia 59 (2016), 2697–2701.
17. Errazuriz, I., Dube, S., Slama, M., Visentin, R., Nayar, S., O'Connor, H., et al. Randomized controlled trial of a MUFA or fiber-rich diet on hepatic fat in prediabetes. J Clin Endocrinol Metab 102 (2017), 1765–1774.
18. Yang, Z.H., Miyahara, H., Iwasaki, Y., Takeo, J., Katayama, M., Dietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-Ay mice. Nutr Metab (Lond), 10, 2013, 16.
19. Ebaid, G.M., Seiva, F.R., Rocha, K.K., Souza, G.A., Novelli, E.L., Effects of olive oil and its minor phenolic constituents on obesity-induced cardiac metabolic changes. Nutr J, 9, 2010, 46.
20. Wang, H., Sit, W.H., Tipoe, G.L., Wan, J.M., Differential protective effects of extra virgin olive oil and corn oil in liver injury: a proteomic study. Food Chem Toxicol 74 (2014), 131–138.
21. Echeverría, F., Ortiz, M., Valenzuela, R., Videla, L.A., Hydroxytyrosol and cytoprotection: a projection for clinical interventions. Int J Mol Sci, 18, 2017, E930.
22. Priore, P., Cavallo, A., Gnoni, A., Damiano, F., Gnoni, G.V., Siculella, L., Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease. IUBMB Life 67 (2015), 9–17.
23. Dyson, J.K., Anstee, Q.M., McPherson, S., Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol 5 (2014), 211–218.
24. Calvaruso, V., Craxì A., Implication of normal liver enzymes in liver disease. J Viral Hepat 16 (2009), 529–536.
25. Fracanzani, A.L., Valenti, L., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48 (2008), 792–798.
26. Verma, S., Jensen, D., Hart, J., Mohanty, S.R., Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int 33 (2013), 1398–1405.
27. Benítez-Arciniega, A.D., Gómez-Ulloa, D., Vila, A., Giralt, L., Colprim, D., Rovira Martori, M.A., et al. Olive oil consumption, BMI, and risk of obesity in Spanish adults. Obes Facts 5 (2012), 52–59.
28. Bes-Rastrollo, M., Sánchez-Villegas, A., de la Fuente, C., de Irala, J., Martinez, J.A., Martínez-González, M.A., Olive oil consumption and weight change: the SUN prospective cohort study. Lipids 41 (2006), 249–256.
29. Soriguer, F., Almaraz, M.C., Ruiz-de-Adana, M.S., Esteva, I., Linares, F., García-Almeida, J.M., et al. Incidence of obesity is lower in persons who consume olive oil. Eur J Clin Nutr 63 (2009), 1371–1374.
30. Flynn, M.M., Reinert, S.E., Comparing an olive oil-enriched diet to a standard lower-fat diet for weight loss in breast cancer survivors: a pilot study. J Women's Health (Larchmt) 19 (2010), 1155–1161.
31. Liu, X., Kris-Etherton, P.M., West, S.G., Lamarche, B., Jenkins, D.J., Fleming, J.A., et al. Effects of canola and high-oleic-acid canola oils on abdominal fat mass in individuals with central obesity. Obesity (Silver Spring) 24 (2016), 2261–2268.
32. Warodomwichit, D., Shen, J., Arnett, D.K., Tsai, M.Y., Kabagambe, E.K., Peacock, J.M., et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity (Silver Spring) 17 (2009), 510–517.
33. Howard, B.V., Hannah, J.S., Heiser, C.C., Jablonski, K.A., Paidi, M.C., Alarif, L., et al. Polyunsaturated fatty acids result in greater cholesterol lowering and less triacylglycerol elevation than do monounsaturated fatty acids in a dose-response comparison in a multiracial study group. Am J Clin Nutr 62 (1995), 392–402.
34. Miller, M., Sorkin, J.D., Mastella, L., Sutherland, A., Rhyne, J., Donnelly, P., et al. Poly is more effective than monounsaturated fat for dietary management in the metabolic syndrome: the muffin study. J Clin Lipidol 10 (2016), 996–1003.
35. Maki, K.C., Lawless, A.L., Kelley, K.M., Kaden, V.N., Geiger, C.J., Palacios, O.M., et al. Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil. Eur J Clin Nutr 71 (2017), 33–38.
36. Qian, F., Korat, A.A., Malik, V., Hu, F.B., Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 39 (2016), 1448–1457.
37. Brunerova, L., Smejkalova, V., Potockova, J., Andel, M., A comparison of the influence of a high-fat diet enriched in monounsaturated fatty acids and conventional diet on weight loss and metabolic parameters in obese non-diabetic and type 2 diabetic patients. Diabet Med 24 (2007), 533–540.
38. Lama, A., Pirozzi, C., Mollica, M.P., Trinchese, G., Di Guida, F., Cavaliere, G., et al. Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats. Mol Nutr Food Res, 61, 2017.
39. Vitaglione, P., Savarese, M., Paduano, A., Scalfi, L., Fogliano, V., Sacchi, R., Healthy virgin olive oil: A matter of bitterness. Crit Rev Food Sci Nutr 55 (2015), 1808–1818.
40. Hohmann, C.D., Cramer, H., Michalsen, A., Kessler, C., Steckhan, N., Choi, K., et al. Effects of high phenolic olive oil on cardiovascular risk factors: a systematic review and meta-analysis. Phytomedicine 22 (2015), 631–640.